LKFT Lakefront Biotherapeutics
$26.81▲ +0.00%
Healthcare
Other
After hours
$26.81▲ +0.00%
Sep 11, 7:30 PM ET
Volume 245.8K
Avg Volume (10D) 186.0K
Key Metrics & Fundamentals
Market Cap
$1.76B
P/E Ratio
2.6
Div Yield
–%
52W Range
25.68 - 37.78
% vs 50 MA
-5.93%
% vs 200 MA
-11.58%
RSI-14
37.8
MACD Histogram
-0.2400
Beta (1Y vs SPY)
0.58
Free Cash Flow
-$34.12M
Gross Rev
$12.11M
Gross Profit
$2.97M
EBITDA
$46.92M
COGS
$9.15M
Operating Exp
$46.48M
Operating Income
-$43.51M
EBIT
-$43.51M
Pretax Income
$2.01M
Net Income
$2.11M
Price & Volume History
Loading chart…
Recent News
Acquisition of Own Shares
GlobeNewswire · Sep 8, 2026 8:02 PM
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 8, 2026 8:01 PM
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
Simply Wall St. · Sep 4, 2026 10:14 PM
Lakefront Gets FDA Orphan Drug Label for Gamgertamig
MT Newswires · Aug 24, 2026 8:53 PM
Lakefront Receives Transparency Notification from Bank of America
GlobeNewswire · Aug 24, 2026 8:01 PM
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
GlobeNewswire · Aug 24, 2026 8:01 PM
Morgan Stanley Adjusts PT on Lakefront Biotherapeutics to $26 From $30, Maintains Equalweight Rating
MT Newswires · Aug 11, 2026 9:31 AM
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 10, 2026 8:01 PM
Earnings To Watch: Lakefront Biotherapeutics NV (XAMS:LKFT) Q2 2026 -- GF Value Sees 474% Upside
GuruFocus.com · Aug 10, 2026 1:17 PM
Earnings To Watch: Lakefront Biotherapeutics NV (XAMS:LKFT) Q2 2026 -- GF Value Sees 496% Upside
GuruFocus.com · Aug 7, 2026 1:17 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See LKFT's money flow as a full page
Social Sentiment
No Reddit posts found for LKFT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.